Zonsen PepLib Biotech Inc.
Rethink Peptide Drug Discovery
Zonsen PepLib Biotech Inc. is an innovative biotechnology company dedicated to the discovery and development of novel peptide‑based therapeutics, with the aim of expanding treatment options for patients worldwide. Founded in September 2017, the company is headquartered in Zhuzhou, China, and maintains subsidiaries in Changsha, China, and New Jersey, USA. Zhongsheng All‑Peptide has established a robust and diversified proprietary peptide library and discovery technology platform, focusing on oncology and cardiovascular‑metabolic diseases. Its platform supports multiple peptide‑based drug formats, including peptide–radionuclide conjugates (PRCs), peptide–oligonucleotide conjugates (POCs), and peptide–drug conjugates (PDCs).
Founded in 2017.
A super-large peptide entity database containing information on nearly 500 million peptides.
Overseas returnees
Science and technology
Product Center
Learn more
Partner Clients
Financing institution
Empowering the thriving development of peptide therapeutics worldwide, enabling cost‑effective access to peptide medicines for patients around the globe, and contributing to human health.
Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd.
Contact Information
Email:info@peplib.com
Company Address: Building 5, Modern Service Industry Headquarters Park, No. 1769 Yunlong Avenue, Yunlong Demonstration Zone, Zhuzhou, Hunan Province
Copyright © 2023 Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd. This website supports IPv6.